Merck

Is Teva Investing Enough in Its Branded Products?
Motley Fool
Tue, 01/8/13 - 12:10 pm
Teva
Merck
Pfizer
Merck CEO Says ‘Worth Thinking About’ Bausch & Lomb Deal
Bloomberg
Tue, 01/8/13 - 08:58 am
Bausch & Lomb
Merck
Kenneth Frazier
M&A
Cancers Linked to HPV Rise in U.S. on Low Vaccine Use
Bloomberg
Mon, 01/7/13 - 06:58 pm
HPV
cervical cancer
Gardasil
Merck
GSK
Cervarix
Merck Emerges As Top Funder Of Digital Health Start-Ups
Forbes
Mon, 01/7/13 - 12:58 pm
Merck
Why the Street Should Love Merck's Earnings
Motley Fool
Mon, 01/7/13 - 10:27 am
Merck
earnings
Merck Still Believes 2 Is Better Than 1
Motley Fool
Mon, 01/7/13 - 10:19 am
Merck
Zetia
Pfizer
Lipitor
Merck resubmits cholesterol combo pill to FDA
Yahoo/AP
Thu, 01/3/13 - 11:31 am
Merck
FDA
MK-0653C
Will Merck's Failure With Tredaptive Impact How Drugs Are Approved in Europe?
Forbes
Wed, 01/2/13 - 11:47 am
Merck
Tredaptive
Europe
Achillion: Poised For Growth And Now Is The Time To Buy
Seeking Alpha
Wed, 01/2/13 - 11:47 am
Achillion
Abbott Labs
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Vertex Pharmaceuticals
Is Prolor Biotech As Long Lasting As Its CTP Technology?
Seeking Alpha
Tue, 01/1/13 - 11:55 am
Prolor Biotech
CTP techonology
Merck
2013 Should Be Interesting for Multiple Sclerosis Drugs
The Motley Fool
Mon, 12/31/12 - 04:36 pm
multiple sclerosis
drugs
Teva Pharmaceuticals
Pfizer
Merck
Biogen
Bayer
Novartis
Will Merck Keep Defying Skeptics in 2013?
Motley Fool
Mon, 12/31/12 - 11:16 am
Merck
Top Alzheimer's Missteps of 2012
Motley Fool
Mon, 12/31/12 - 11:14 am
Alzheimer's disease
Medivation
Pfizer
Eli Lilly
JNJ
Merck
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
HCV
Vertex Pharmaceuticals
Merck
Gilead Sciences
Abbott Laboratories
hepatitis C
Achillion
Idenix
JNJ
GSK
Merck & Co Inc (MRK): Today's Featured Drugs Laggard
The Street
Sat, 12/29/12 - 09:55 am
Merck
2012 Roundup -- HCV Treatments
Motley Fool
Fri, 12/28/12 - 11:36 am
hepatitis C
Vertex Pharmaceuticals
Gilead
Merck
Abbott Labs
Achillion
GSK
JNJ
Idenix
Bristol-Myers Squibb
Pfizer Playing the Right Card Amid Changing Sector Landscape
Motley Fool
Fri, 12/28/12 - 11:31 am
Pfizer
Merck
JNJ
This Beaten Down Drug Company Can Provide Value in 2013
Motley Fool
Wed, 12/26/12 - 09:22 pm
Merck
Investments In Novel IL-12 Adminstration Platforms In The Fight Against Cancer
Seeking Alpha
Wed, 12/26/12 - 09:27 am
Merck
OncoSec
Ziopharm
Interleukin-12
Lessons From Merck's Niacin Failure
Forbes
Mon, 12/24/12 - 10:27 am
Tredaptive
Merck

Pages